搜尋結果
TD Probe Tied to Laundering Money From Drug Sales, Journal Says
Bloomberg· 1 日前A US law-enforcement probe into Toronto-Dominion Bank’s internal controls is tied to the ...
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug
Reuters· 3 日前Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice ...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 2 日前Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition ...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters· 1 日前, opens new tab missed Wall Street estimates for quarterly profit on Thursday, hurt by softer ...
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 22 小時前, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost ...
Zoetis Stock Jumps After Sales Beat, Leaders Emphasize Safety of Key Arthritis Drugs
The Wall Street Journal· 1 日前Zoetis jumped more than 6% in Thursday morning trading as leaders of the animal-health company ...
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg· 1 日前Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 3 日前, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales forecast ...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 4 日前The Federal Trade Commission is challenging hundreds of alleged “junk” patent listings filed by ...
Lilly Raises 2024 Guidance as Zepbound Flies Off Shelves
Bloomberg· 3 日前Eli Lilly & Co.’s shares jumped after it raised its annual guidance on soaring demand for its ...